4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

968.18p
   
  • Change Today:
    -1.82p
  • 52 Week High: 1,500.00p
  • 52 Week Low: 930.00p
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 3,027
  • Market Cap: £150.44m

Latest Deals

Traded Action Notifier PriceAmountValue
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,117,688 £10,821,252
Amy Walker 44,016 £426,155
Maria Del Pilar de la Huerta 6,667 £64,549
Hansjörg Plaggemars 6,667 £64,549

Major Shareholders

Notifier** Holding Value*
Wilhelm K. T. Zours 5,119,743 £49,568,421
DELPHI Unternehmensberatung AG 5,119,743 £49,568,421
4bb AG 5,115,852 £49,530,749
M&G Plc 4,627,741 £44,804,947
Elevage Medical Technologies Holdings 4,627,741 £44,804,947
Deutsche Balaton AG 4,432,637 £42,915,986
2invest AG 2,229,083 £21,581,576
Sparta AG 1,351,718 £13,087,088
Latonba AG 778,891 £7,541,081
Franciscus De Busschere 537,255 £5,201,605

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 968.18p
Change Today -1.82p
% Change -0.19 %
52 Week High 1,500.00p
52 Week Low 930.00p
Volume 3,027
Shares Issued 15.54m
Market Cap £150.44m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.57% below the market average66.57% below the market average66.57% below the market average66.57% below the market average66.57% below the market average
2.33% above the sector average2.33% above the sector average2.33% above the sector average2.33% above the sector average2.33% above the sector average
Price Trend
25.45% below the market average25.45% below the market average25.45% below the market average25.45% below the market average25.45% below the market average
6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average
Income Not Available
Growth
59.34% above the market average59.34% above the market average59.34% above the market average59.34% above the market average59.34% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

4basebio Dividends

No dividends found

Trades for 11-Aug-2025

Time Volume / Share Price
09:09 1,500 @ 940.00p
09:30 400 @ 930.70p
08:07 1,100 @ 1,000.00p
08:20 4 @ 930.00p
08:19 22 @ 930.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page